View Author
patient hiv-infected hiv-infected participants study control coagulation marker participant cell activation protein level follow-up therapy haemostasis 104.6/2010 downloaded 2012-04-19 | id venou 1000521777 | ip hiv-infected patients antiretroviral therapy factor activation thrombosis population initiation africa venous thromboembolism baseline anticoagulation anti-retroviral therapy step 2 antiretroviral parameter apcsr d-dimer levels von willebrand factor coagulation parameters d-dimer range mortality haemostatic balance department infection netherland coagulation markers baseline characteristics laboratory individual risk factors protein c effect venous compression ultrasound helen joseph hospital count hospital antibody weight right tuberculosis venous ultrasound thromboembolism interquartile range regression analysis haemostasi immunodeficiency virus immunodeficiency medicine thrombin thromb result characteristic difference plasma ethnicity group african disease variable virus anti-retroviral 2012-04-19
2 Most Recent Publications
|
The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals
(Article)
Jong, E. Louw, S. Gorp, E.C.M. van Meijers, J.C.M. Cate, H.T. Jacobson, B.F. |
2010-12-01
|
|
Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: Lipopolysaccharide as a case study
(Article)
Hettne, K.M. Weeber, M. Laine, M.L. Cate, H.T. Boyer, S. Kors, J.A. Loos, B.G. |
2007-12-01
|